Alogliptin Associated With Lower Fracture Risk Than Linagliptin, Saxagliptin in T2D
Alogliptin Associated With Lower Bone Fracture Risk in T2D
Perioperative major adverse cardiovascular and cerebrovascular events may be more common in patients with diabetes.
Investigators sought to determine an association between diabetes and HbA1C with postoperative outcomes.
Overall, once-weekly semaglutide 1.0 mg as an add-on to basal insulin is the most efficacious GLP-1 receptor agonist in terms of reductions in HbA1c and body weight from baseline after ...